Integrated Wealth Concepts’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-752
| Closed | -$477K | – | 1986 |
|
|
2025
Q1 | $477K | Sell |
752
-411
| -35% | -$261K | 0.01% | 1167 |
|
|
2024
Q4 | $828K | Buy |
1,163
+415
| +55% | +$296K | 0.01% | 900 |
|
|
2024
Q3 | $786K | Buy |
748
+214
| +40% | +$225K | 0.01% | 899 |
|
|
2024
Q2 | $561K | Buy |
534
+30
| +6% | +$31.5K | 0.01% | 999 |
|
|
2024
Q1 | $485K | Buy |
504
+102
| +25% | +$98.2K | 0.01% | 1069 |
|
|
2023
Q4 | $353K | Sell |
402
-55
| -12% | -$48.3K | 0.01% | 1175 |
|
|
2023
Q3 | $376K | Sell |
457
-36
| -7% | -$29.6K | 0.01% | 1115 |
|
|
2023
Q2 | $354K | Buy |
493
+5
| +1% | +$3.59K | 0.01% | 1150 |
|
|
2023
Q1 | $401K | Buy |
488
+142
| +41% | +$117K | 0.01% | 933 |
|
|
2022
Q4 | $250K | Sell |
346
-176
| -34% | -$127K | 0.01% | 873 |
|
|
2022
Q3 | $360K | Sell |
522
-518
| -50% | -$357K | 0.01% | 685 |
|
|
2022
Q2 | $615K | Buy |
1,040
+492
| +90% | +$291K | 0.02% | 545 |
|
|
2022
Q1 | $383K | Sell |
548
-16
| -3% | -$11.2K | 0.01% | 654 |
|
|
2021
Q4 | $356K | Buy |
564
+19
| +3% | +$12K | 0.01% | 704 |
|
|
2021
Q3 | $330K | Buy |
545
+118
| +28% | +$71.5K | 0.01% | 702 |
|
|
2021
Q2 | $238K | Buy |
+427
| New | +$238K | 0.01% | 719 |
|
|
2021
Q1 | – | Sell |
-546
| Closed | -$264K | – | 763 |
|
|
2020
Q4 | $264K | Buy |
546
+65
| +14% | +$31.4K | 0.01% | 541 |
|
|
2020
Q3 | $269K | Buy |
481
+28
| +6% | +$15.7K | 0.02% | 478 |
|
|
2020
Q2 | $283K | Buy |
+453
| New | +$283K | 0.02% | 420 |
|